PharmiWeb.com - Global Pharma News & Resources
04-Mar-2021

At 5.4% CAGR Epistaxis Market To Hit US$ 221.8 Million By 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global epistaxis market, by indication (Anterior Epistaxis and Posterior Epistaxis), by product type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents), by distribution channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 145.9 million in 2019 and is projected to exhibit a CAGR of 5.4% over the forecast period (2019-2027).

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/771

Increasing cases of nasal tumors of both benign and malignant types is a major aspect foreseen to accelerate the growth of the global epistaxis market over the projected period. As per the 2018 report published by the American Cancer Society, around 2,000 new cases of nasal cavity and paranasal sinuses are registered in the U.S. every year. The report further stated that these sinuses are highly accountable for epistaxis, and are more prevalent in certain parts of the world, including South Africa and Japan. Furthermore, increasing instances of emergency admissions and inpatient admissions contribute to the global market growth. In 2018, the National Center for Biotechnology Information (NCBI) reported that around two out of every 200 visits to the emergency departments in the U.S. are due to epistaxis.

Rising prevalence of cardiovascular disorders, especially hypertensive diseases, which bear a high risk of hemorrhage, is a major growth stimulator for the global market. According to the Medical Statistics of World Health Organization, around 289,000 cases of hypertension among pregnant women were recorded in 2015. According to the American Pregnancy Organization, the circulatory system expands during pregnancy, which leads to increased blood circulation, which might give rise to problematic issues and frequent nosebleeds during pregnancy. Thus, rising number of pregnant women suffering from hypertensive diseases is expected to boost the global market growth in the near future.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/771

Key Takeaways of the Global Epistaxis Market:

  • In terms of indication, the anterior epistaxis segment is poised to accumulate a major revenue share in the global epistaxis market by 2027.
  • The renowned companies operating in the global epistaxis market include Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/epistaxis-market-to-surge-beyond-us-200-million-by-2025-underpinned-by-high-prevalence-of-hypertension-and-trauma-cases-339

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Indication
      • Market Snippet, By Product Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Industry Trend
    • Mergers and Acquisitions
    • Technology Overview
    • Regulatory Scenario
    • Epidemiology
    • New Product Approvals/Launches
    • PEST Analysis
  4.  Global Epistaxis Market, By Indication, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Anterior Epistaxis
    • Posterior Epistaxis
  5. Global Epistaxis Market, By Product Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Vasoconstrictors
    • Anesthetics
    • Antibiotic Ointments
    • Cauterizing Agents
  6. Global Epistaxis Market, By Distribution Channel, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  7. Global Epistaxis Market, By Region, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Product Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Smith & Nephew*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medline Industries, Inc.
      • Bristol-Myers Squibb Pharma Company
      • Ciron Drugs
      • King Pharmaceuticals, Inc.
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Mar-2021